CIPLA LTD. - Updates on Subsidiary

	< Back
05 Sep 2014
Cipla Ltd has informed BSE that Medispray Laboratories Private Limited, a wholly owned subsidiary of the Company at its board meeting held on September 05, 2014 approved the acquisition of two manufacturing undertakings. A significant portion of the capacities of the two undertakings are dedicated for the manufacture of Cipla's products. Acquisition of the aforesaid undertakings is expected to yield operational synergies.<br/><br/>The consideration for the above two transactions are Rs. 29 crore and Rs. 71.93 crore respectively. The first manufacturing facility located at Goa is owned by Okasa Private Limited and the second manufacturing facility located at Satara (Maharashtra) is owned by Okasa Pharma Pvt Ltd. Entities controlled by relatives of the promoters hold majority interest in the companies which own the aforesaid undertakings.<br/><br/>The consideration for these transactions were supported on the basis of valuation reports from Price Waterhouse and Co. LLP and fairness opinions provided by Kotak Mahindra Capital Company Limited.
View all announcements for CIPLA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us